The expense management firm projects improved cash flow next year amid share repurchases and a narrower net loss in Q2 2026. Expensify guided to $12 million to $14 million in free cash flow for 2026, supported by share repurchase plans. The company reported Q2 2026 revenue
Informa TechTarget reaffirms its 2026 adjusted EBITDA outlook as customer spending remains subdued in Q2 2026. Informa TechTarget (TTGT) has reiterated its adjusted EBITDA guidance of $95M-$100M for 2026, despite ongoing cautious customer spending. The company’s outlook re
June’s surplus fell below forecasts as imports outpaced exports, marking the lowest level since March amid rising demand. Germany’s trade surplus contracted to €15.4 billion in June, down from an upwardly revised €19.3 billion in May and below the €17.4 billion estimate. T
The software firm projects 41%-43% baseline cloud growth, underpinning its 2026 revenue forecast after Q2 results topped guidance. JFrog set its 2026 revenue outlook at $648 million to $652 million, reflecting confidence in sustained cloud expansion. The company cited 41%-
KWY management confirms acquisition target range after quarterly EBITDA exceeds internal forecasts by a wide margin. Kingsway Corporation reported Q2 2026 portfolio EBITDA of $7.2M, marking its strongest operating quarter under current leadership and surpassing internal pr
The rare earth producer forecasts Q3 neodymium-praseodymium production above 1,000 metric tons amid magnetics expansion. MP Materials expects neodymium-praseodymium (NdPr) production to exceed 1,000 metric tons in Q3 2026, reflecting continued scaling of its materials and
Navient reports Q2 2026 core earnings of $0.29 per share, adjusting to fair value accounting for new originations. Navient posted Q2 2026 core earnings of $0.29 per share, up from an adjusted $0.25 excluding one-time items. The company cited a gain on investment, partially
New 15% tariffs and price floors on foreign polysilicon imports spark a rally in U.S. solar equities, though quant ratings highlight divergence. U.S. solar stocks climbed following the imposition of 15% tariffs and price floors on foreign polysilicon imports, a move aimed
Lineage Cell Therapeutics projects cash sufficiency into late 2028 and targets in vivo data for its COR1 program by year-end. Lineage Cell Therapeutics (LCTX) announced it has secured cash reserves to fund operations through Q3 2028. The extension follows progress in its O
Fox increases its semi-annual dividend by 3.6% to $0.29, yielding 0.94% with a September 23 payout date. Fox announced a 3.6% increase in its semi-annual dividend to $0.29 per share, up from the prior $0.28. The dividend yields 0.94% based on current share prices. T
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.